ABOUT THE BRIDGE INITIATIVE
In 2020, CureSearch established a partnership with FasterCures, a center of the Milken Institute and the Children’s Tumor Foundation to identify deprioritized drugs that could benefit pediatric patients and to create a new pediatric-focused pathway for development.
This partnership is the first under FasterCures’ BRIDGE initiative launched in 2019 with a mission to enable more dynamic marketplaces for biomedical innovation.
Drugs can be deprioritized by biopharmaceutical companies for a variety of strategic or commercial reasons and that can lead to missed opportunities for children with cancer.
The team developed a new approach to solving this challenge by assigning patient advocacy groups, and other nonprofit organizations, as matchmakers between discontinued drug assets and capital sources.
In September 2021, the team published lessons learned from the pilot Bridge Initiative.
Read the full report: Creating a Nonprofit Marketplace for Shelved Drugs: Lessons from a Pilot Project.
“This initiative will enable us to identify those opportunities and match them with development expertise and financial support to ensure that promising therapies are expedited to the children who are counting on us,"
Kay Koehler, President and CEO of CureSearch
Our press release about this collaboration can be found here.
Pharmaceutical representatives can contact Chris Riley, National Director of Corporate Healthcare Partnerships, for more information: email@example.com or (240) 235-2217.